14158 Results (Page 433 of 567)
All Market Research Reports
Brazil Depression Therapeutics Market Analysis
The Brazil depression therapeutics market is expected to witness growth from $253 Mn in 2022 to $409 Mn in 2030 with a CAGR of 6.2% for the forecasted year 2022-2030. The rise in healthcare spending and new research and development projects for depression treatment by various pharmaceutical firms in Brazil are responsible for the expansion of the market. The Brazil depression therapeutics market is segmented by drug type, therapies, indication, and by end users. Neo Química, Mantecorp Farmasa, and Elly Lilly are the major players in the Brazil depression therapeutics market.
Australia Depression Therapeutics Market Analysis
The Australian depression therapeutics market is expected to witness growth from $121 Mn in 2022 to $204 Mn in 2030 with a CAGR of 6.7% for the forecasted year 2022-2030. The development of newer and innovative therapeutics by Australian pharmaceutical companies and the increased demand for personalized depression treatment in Australia are driving the growth of the market. The Australian depression therapeutics market is segmented by drug type, therapies, indication, and by end users. Kira Biotech, Zucero Therapeutics, and Pfizer are the major players in the Australian depression therapeutics market.
UK Biomaterials in Healthcare Market Analysis
The UK Biomaterials Healthcare Market is expected to witness growth from $4.06 Bn in 2022 to $9.49 Bn in 2030 with a CAGR of 11.20% for the forecasted year 2022-2030. In the UK, the prevalence of chronic illnesses like osteoarthritis, diabetes, and cardiovascular disease is rising. The demand for biomaterials in the healthcare sector is being driven by the ability to use them to make medical implants and devices that can aid in the management of these diseases. The market is segmented by type and by application. Some key players in this market include Camstent, Renovos Biologics, Collagen Solutions, BASF SE, Celanese, and Evonik Industries.
Spain Biomaterials in Healthcare Market Analysis
The Spain Biomaterials Healthcare Market is expected to witness growth from $3.01 Bn in 2022 to $7.57 Bn in 2030 with a CAGR of 12.20% for the forecasted year 2022-2030. In Spain, Biomaterials are used in the developing area of regenerative medicine to repair or replace diseased or damaged tissues and organs. This is fuelling demand for biomaterials in Spain's healthcare market. The market is segmented by type and by application. Some key players in this market include Bioiberica, Regemat, Quimatryx, BASF SE, Celanese, Covestro AG and Evonik Industries.
Italy Biomaterials in Healthcare Market Analysis
The Italy Biomaterials Healthcare Market is expected to witness growth from $3.75 Bn in 2022 to $9.75 Bn in 2030 with a CAGR of 12.70% for the forecasted year 2022-2030. The prevalence of persistent illnesses like diabetes, cancer, and cardiovascular disease is increasing in Italy. which fuels the demand for biomaterials in the healthcare sector in Italy. As a consequence, the biomaterials healthcare market in Italy is growing. The market is segmented by type and by application. Some key players in this market include Finceramica Faenza, Lima Corporate, Serbios, BASF SE, Celanese, and Evonik Industries.
India Biomaterials in Healthcare Market Analysis
The India Biomaterials Healthcare Market is expected to witness growth from $2.84 Bn in 2022 to $9.44 Bn in 2030 with a CAGR of 16.20% for the forecasted year 2022-2030. India's large and ageing population increases its susceptibility to serious illnesses including osteoarthritis and cardiovascular disease, which usually require the use of biomaterials as a therapy, leading to the growth of the country's biomaterial healthcare industry. The market is segmented by type and by application. Some key players in this market include Poly Medicure, Sahajanand Medical Technologies, MicroPort, BASF SE, Celanese, Covestro AG and Evonik Industries.
Germany Biomaterials in Healthcare Market Analysis
The Germany Biomaterials Healthcare Market is expected to witness growth from $5.71 Bn in 2022 to $13.56 Bn in 2030 with a CAGR of 11.40% for the forecasted year 2022-2030. A growing need for regenerative medicine and an ageing populace are the main factors driving Germany's biomaterials healthcare market. The market is segmented by type and by application. Some key players in this market include Evonik Industries, Merck KGaA, Matricel, BASF SE, Covestro AG and Celanese.
France Biomaterials in Healthcare Market Analysis
The France Biomaterials Healthcare Market is expected to witness growth from $4.29 Bn in 2022 to $10.79 Bn in 2030 with a CAGR of 12.20% for the forecasted year 2022-2030. In France, there is a rising demand for minimally invasive procedures that use speciality biomaterials. Manufacturers who can create products that work with minimally invasive procedures have an edge over rivals in the market. The demand for biomaterials used in orthopaedics, cardiology, and other medical uses is rising in France as a result of the country's ageing population. The market is segmented by type and by application. Some key players in this market include Sofradim Production, Arthrex France, Carthera, BASF SE, Evonik Industries and Medtronic.
UAE Liver Cancer Therapeutics Market Analysis
By 2030, it is anticipated that the UAE liver cancer therapeutics market will reach a value of $57.3 Mn from $14.7 Mn in 2022, growing at a CAGR of 18.6% during 2022-30. The liver cancer therapeutics in UAE is dominated by a few domestic pharmaceutical companies such as Neopharma, Julphar, and Medpharma. The liver cancer therapeutics market in UAE is segmented into different types of cancer and different therapy type. Some of the major factors affecting this market are the growing prevalence of liver cancer and the high cost and side effects related to certain liver cancer therapies.
China Biomaterials in Healthcare Market Analysis
The China Biomaterials Healthcare Market is expected to witness growth from $12.56 Bn in 2022 to $37.62 Bn in 2030 with a CAGR of 14.70% for the forecasted year 2022-2030. One of the world's biggest ageing populations is found in China. Medical implants and devices made of biomaterials are in greater demand as the population ages in China. The market is segmented by type and by application. Some key players in this market include Weigao Group, Suzhou Sinomed, MicroPort, BASF SE, Celanese, Covestro AG and Evonik Industries.
Philippines Liver Cancer Therapeutics Market Analysis
By 2030, it is anticipated that the Philippines liver cancer therapeutics market will reach a value of $24.4 Mn from $6.45 Mn in 2022, growing at a CAGR of 18.1% during 2022-30. The liver cancer therapeutics market in the Philippines is dominated by a few domestic pharmaceutical companies such as United Laboratories, Pascual Laboratories, and Philippine Pharma Resources. The liver cancer therapeutics market in the Philippines is segmented into different types of cancer and different therapy type. Some of the major factors affecting this market are the growing prevalence of liver cancer and the high cost and side effects related to certain liver cancer therapies.
Japan Liver Cancer Therapeutics Market Analysis
By 2030, it is anticipated that the Japan liver cancer therapeutics market will reach a value of $689.2 Mn from $182.12 Mn in 2022, growing at a CAGR of 18.1% during 2022-30. The liver cancer therapeutics market in Japan is dominated by a few domestic pharmaceutical companies such as Chugai Pharmaceutical, Taiho Pharmaceutical, and Eisai. The liver cancer therapeutics market in Japan is segmented into different types of cancer and different therapy type. Some of the major factors affecting this market are the growing prevalence of liver cancer and the high cost and side effects related to certain liver cancer therapies.
Indonesia Liver Cancer Therapeutics Market Analysis
By 2030, it is anticipated that the Indonesia liver cancer therapeutics market will reach a value of $64.3 Mn from $17.58 Mn in 2022, growing at a CAGR of 17.6% during 2022-30. The liver cancer therapeutics market in Indonesia is dominated by a few domestic pharmaceutical companies such as Chugai Pharmaceutical, Taiho Pharmaceutical, and Eisai. The liver cancer therapeutics market in Indonesia is segmented into different types of cancer and different therapy type. Some of the major factors affecting this market are the growing prevalence of liver cancer and the high cost and side effects related to certain liver cancer therapies.
India Liver Cancer Therapeutics Market Analysis
By 2030, it is anticipated that the India liver cancer therapeutics market will reach a value of $238.4 Mn from $53.3 Mn in 2022, growing at a CAGR of 20.6% during 2022-30. The liver cancer therapeutics in India is dominated by a few domestic pharmaceutical companies such as Dr. Reddy's Laboratories, HCG Hospitals, and Natco Pharma. The liver cancer therapeutics market in India is segmented into different types of cancer and different therapy type. Some of the major factors affecting this market are the growing prevalence of liver cancer and the high cost and side effects related to certain liver cancer therapies.
Egypt Liver Cancer Therapeutics Market Analysis
By 2030, it is anticipated that the Egypt liver cancer therapeutics market will reach a value of $33.2 Mn from $8.2 Mn in 2022, growing at a CAGR of 19.1% during 2022-30. The liver cancer therapeutics market in Egypt is dominated by a few domestic pharmaceutical companies such as Pharco Pharmaceuticals, EIPICO, and Memac Pharma. The liver cancer therapeutics market in Egypt is segmented into different types of cancer and different therapy type. Some of the major factors affecting this market are the growing prevalence of liver cancer and the high cost and side effects related to certain liver cancer therapies.
UAE Lung Cancer Therapeutics Market Analysis
By 2030, it is anticipated that the UAE Lung Cancer Therapeutics Market will reach a value of $299 Mn from $149 Mn in 2022, growing at a CAGR of 9.1% during 2022-2030. The Lung Cancer Therapeutics Market in UAE is dominated by a few domestic pharmaceutical companies such as Gulf Pharmaceutical Industries, Neopharma, and SITCO. The Lung Cancer Therapeutics Market in UAE is segmented into different types of cancer and different therapy type. Some of the major factors affecting the UAE lung cancer therapeutics market are the prevalence of unhealthy lifestyles, demand for targeted therapies and the presence of highly efficient drugs.
China Liver Cancer Therapeutics Market Analysis
By 2030, it is anticipated that the China liver cancer therapeutics market will reach a value of $953.6 Mn from $235.5 Mn in 2022, growing at a CAGR of 19.1% during 2022-30. The liver cancer therapeutics market in China is dominated by a few domestic pharmaceutical companies such as BeiGene, Chi-Med, and Jiangsu HengRui Medicine. The liver cancer therapeutics market in China is segmented into different types of cancer and different therapy type. Some of the major factors affecting this market are the growing prevalence of liver cancer and the high cost and side effects related to certain liver cancer therapies.
Brazil Liver Cancer Therapeutics Market Analysis
By 2030, it is anticipated that the Brazil liver cancer therapeutics market will reach a value of $286.7 Mn from $73.25 Mn in 2022, growing at a CAGR of 18.6% during 2022-30. The liver cancer therapeutics market in Brazil is dominated by a few domestic pharmaceutical companies such as Eurofarma, Aché Laboratórios, and Libbs Farmacêutica. The liver cancer therapeutics market in Brazil is segmented into different types of cancer and different therapy type. Some of the major factors affecting this market are the growing prevalence of liver cancer and the high cost and side effects related to certain liver cancer therapies.
Thailand Lung Cancer Therapeutics Market Analysis
By 2030, it is anticipated that the Thailand Lung Cancer Therapeutics Market will reach a value of $68 Mn from $36 Mn in 2022, growing at a CAGR of 8.5% during 2022-2030. The Lung Cancer Therapeutics Market in Thailand is dominated by a few domestic pharmaceutical companies such as Siam Bioscience, Bangkok Labs, and Bio Net-Asia. The Lung Cancer Therapeutics Market in Thailand is segmented into different types of cancer and different therapy type. Some of the major factors affecting the Thailand lung cancer therapeutics market are the prevalence of unhealthy lifestyles, demand for targeted therapies and the presence of highly efficient drugs.
Australia Liver Cancer Therapeutics Market Analysis
By 2030, it is anticipated that the Australia liver cancer therapeutics market will reach a value of $142.3 Mn from $35.2 Mn in 2022, growing at a CAGR of 19.1% during 2022-30. Liver cancer therapeutics in Australia is dominated by a few domestic pharmaceutical companies such as Imugene Limited, Kazia Therapeutics, and Sirtex Medical Limited. Liver cancer therapeutics in Australia is segmented into different types of cancer and different therapy type. Some of the major factors affecting this market are the growing prevalence of liver cancer and the high cost and side effects related to certain liver cancer therapies.
Spain Lung Cancer Therapeutics Market Analysis
By 2030, it is anticipated that the Spain Lung Cancer Therapeutics Market will reach a value of $996 Mn from $575 Mn in 2022, growing at a CAGR of 7.1% during 2022-2030. The Lung Cancer Therapeutics Market in Spain is dominated by a few domestic pharmaceutical companies such as Grifols, PharmaMar, and Almirall. The Lung Cancer Therapeutics Market in Spain is segmented into different types of cancer and different therapy type. Some of the major factors affecting the Spain lung cancer therapeutics market are the prevalence of unhealthy lifestyles, demand for targeted therapies and the presence of highly efficient drugs.
South Korea Lung Cancer Therapeutics Market Analysis
By 2030, it is anticipated that the South Korea Lung Cancer Therapeutics Market will reach a value of $875 Mn from $435 Mn in 2022, growing at a CAGR of 9.1% during 2022-2030. The Lung Cancer Therapeutics Market in South Korea is dominated by a few domestic pharmaceutical companies such as Yuhan Corporation, Hanmi Pharmaceutical, and Celltrion Healthcare. The Lung Cancer Therapeutics Market in South Korea is segmented into different types of cancer and different therapy type. Some of the major factors affecting the South Korean lung cancer therapeutics market are the prevalence of unhealthy lifestyles, demand for targeted therapies and the presence of highly efficient drugs.
South Africa Lung Cancer Therapeutics Market Analysis
By 2030, it is anticipated that the South Africa Lung Cancer Therapeutics Market will reach a value of $396 Mn from $194 Mn in 2022, growing at a CAGR of 9.3% during 2022-2030. The Lung Cancer Therapeutics Market in South Africa is dominated by a few domestic pharmaceutical companies such as Akacia Medical, Adcock Ingram, and Aspen Pharmacare. The Lung Cancer Therapeutics Market in South Africa is segmented into different types of cancer and different therapy type. Some of the major factors affecting the South African lung cancer therapeutics market are the prevalence of unhealthy lifestyles, demand for targeted therapies and the presence of highly efficient drugs.
Singapore Lung Cancer Therapeutics Market Analysis
By 2030, it is anticipated that the Singapore Lung Cancer Therapeutics Market will reach a value of $70 Mn from $36 Mn in 2022, growing at a CAGR of 8.7% during 2022-2030. The Lung Cancer Therapeutics Market in Singapore is dominated by a few domestic pharmaceutical companies such as Roche Singapore, ASTAR Biomedical, and National Cancer Centre Singapore. The Lung Cancer Therapeutics Market in Singapore is segmented into different types of cancer and different therapy type. Some of the major factors affecting the Singapore lung cancer therapeutics market are the prevalence of unhealthy lifestyles, demand for targeted therapies and the presence of highly efficient drugs.
Saudi Arabia Lung Cancer Therapeutics Market Analysis
By 2030, it is anticipated that the Saudi Arabia Lung Cancer Therapeutics Market will reach a value of $1056 Mn from $507 Mn in 2022, growing at a CAGR of 9.6% during 2022-2030. The Lung Cancer Therapeutics Market in Saudi Arabia is dominated by a few domestic pharmaceutical companies such as Tabuk Pharmaceuticals, BioVet, and SPIMACO. The Lung Cancer Therapeutics Market in Saudi Arabia is segmented into different types of cancer and different therapy type. Some of the major factors affecting the Saudi Arabia lung cancer therapeutics market are the prevalence of unhealthy lifestyles, demand for targeted therapies and the presence of highly efficient drugs.
